Beyond the Surface: Tailored Solutions for Tear Evaporation in Meibomian Gland Dysfunction : Episode 4

Factors to Consider in Treatment Selection for MGD

July 16, 2024

By Jessilin Quint, OD, MBA, MS, FAAO
Selina R. McGee, OD, FAAO, Dipl ABO

Opinion

Video

Selina McGee, OD, FAAO, and Jessilin Quint, OD, MBA, FAAO, discuss the first-line treatment of MGD, highlighting factors that inform treatment selection.

EP: 1.Overview of MGD and Its Causes

EP: 2.Differentiating Aqueous vs Evaporative Dry Eye

EP: 3.Long-Term Consequences of Untreated MGD

Now Viewing

EP: 4.Factors to Consider in Treatment Selection for MGD

EP: 5.Managing Evaporative Dry Eye with New FDA-Approved Therapy

EP: 6.Differentiating Between the Semi-Fluorinated Alkane-Based Therapies for Dry Eye

EP: 7.Combining In-Office and At-Home Therapies

EP: 8.Clinical Case Scenario: Management Strategies for MGD and Key Takeaways

Video content above is prompted by the following questions:

What is your first-line treatment for MGD? What factors do you consider when selecting treatment options for MGD for your patients?